Mobileye Stock Is Tanking. Self-Driving Hype Isn’t Helping Everyone.
Shares of Mobileye fell early Thursday after the self-driving-technology company issued disappointing financial forecasts for 2025. Falling sales aren’t great, but Wall Street was looking for about ...
Institutional owners may consider drastic measures as Recursion Pharmaceuticals, Inc.'s (NASDAQ:RXRX) recent US$130m drop adds to long-term losses
To get a sense of who is truly in control of Recursion Pharmaceuticals, Inc. ( NASDAQ:RXRX ), it is important to understand the ownership structure of the business. With 66% stake, institutions ...
Use A Simple Option Trade To Profit From Robinhood's Earnings Report
Investing in a stock with a high dividend yield can be a great way to generate a lot of passive income. Unfortunately, ...
Is Recursion Pharmaceuticals (RXRX) the Cheap AI Stock to Buy in 2025?
We recently published a list of 12 Cheap AI Stocks to Buy in 2025. In this article, we are going to take a look at where ...
12 Cheap AI Stocks to Buy in 2025
Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with ...
bovnews2d
What’s Driving Recursion Pharmaceuticals Inc (RXRX) Stock’s 21.56% Surge Over the Past Month?
Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $7.33 which represents a decrease of $-0.20 or -2.66% from the prior close of $7.53. The stock opened at $7.64 and touched a ...
Recursion Pharmaceuticals call volume above normal and directionally bullish
Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 20,041 calls trading, 1.8x expected, and implied vol increasing over 2 ...
Stargate Project’s healthcare winners: AI-led biotechs and Metagenomi
The Stargate Project, a $500B initiative focused on artificial intelligence, lifted AI-driven biotech stocks this week while boosting an unlikely winner, Metagenomi (NASDAQ:MGX), which benefitted from ...
FY2024 EPS Estimates for RXRX Decreased by Leerink Partnrs
Leerink Partnrs cut their FY2024 earnings estimates for shares of Recursion Pharmaceuticals in a research note issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now expects that ...
Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last?
Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in ...
bovnews7d
Recursion Pharmaceuticals Inc (RXRX) Stock Sees Market Value Hit $2.93 billion: What Are the Implications?
Recursion Pharmaceuticals Inc (RXRX) stock saw a modest uptick, ending the day at $7.49 which represents a slight increase of $0.61 or 8.87% from the prior close of $6.88. The stock opened at $7.17 ...
Investing7d
Abcellera Biologics, other AI health stocks gain as Ellison touts AI's promise
During a speech at the White House on Tuesday, Ellison emphasized AI's ability to detect cancer early through blood tests and its crucial role in creating individualized vaccines rapidly. This ...